Knowledge Leaders Capital’s AstraZeneca AZN Stock Holding History

Knowledge Leaders Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,858	Closed	-$533K	–	99
2022 Q3	$533K	Sell	4,858 -514	-10%	-$65.2K	0.68%	61
2022 Q2	$710K	Buy	5,372 +31	+0.6%	+$4.07K	0.69%	61
2022 Q1	$709K	Hold	5,341	–	–	0.51%	76
2021 Q4	$622K	Buy	5,341 +445	+9%	+$52.4K	0.46%	92
2021 Q3	$588K	Buy	+4,896	New	+$570K	0.47%	85

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Knowledge Leaders Capital's AZN Position: Q4 2022 in Review

Knowledge Leaders Capital sold out of AstraZeneca (AZN) in Q4 2022, closing a stake of 4,858 shares — an estimated $533K sold.

Knowledge Leaders Capital first reported a position in AZN in Q3 2021 and held it in 5 quarters. The position peaked at $710K in Q2 2022. 1,061 funds tracked by Wall St. Rank hold AZN as of Q4 2022.

Knowledge Leaders Capital reported no remaining AstraZeneca position as of Q4 2022 after selling out during the quarter.
Knowledge Leaders Capital sold 4,858 AstraZeneca shares in Q4 2022, an estimated $533K.
Knowledge Leaders Capital first reported a position in AstraZeneca in Q3 2021 and held it in 5 quarters.
Knowledge Leaders Capital's AstraZeneca position peaked at $710K in Q2 2022.
1,061 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2022.

Based on Knowledge Leaders Capital's 13F filing for Q4 2022, filed 7 Feb 2023.